but less than 12 hrs in duration. Total study period was between August 2010 to October 2013. Total number of patient was 73.
Electrocardiographic criteria were associated with ST segment elevation of > 2mm in chest leads & >1mm in limb leads in >2 contiguous leads. Prior to primary PCI informed written consent were taken from the patient or guardians. All these patient underwent primary PCI as mode of reperfusion through femoral route. All patient in emergency department received Aspirin 300mg, clopidogrel 600 mg as per indication. Patient underwent diagnostic angiogram followed by primary PCI of the infarct related artery.
After thrombus suction where required from the occluded site by a thrombuster sucker, balloon dilatation was done in selected cases. All culprit lesions were stented mostly with bare metal stent (BMS) and few of them by drug Eluting stent (DES). Further smoothening was done by post dilatation whenever required. IVUS was not available in our hospital. Before PCI standard heparin 10,000 units IV bolus was given. Glycoprotein (GP) llb/IIIa antagonist, Eptifibatide was used both as intra coronary bolus and I.V maintenance in all cases. Intracoronary nitrates & adenosine use were at the judgement of the operator. Stent size selection was primarily based on visual assessment of lesion length and vessel diameter. All patients were prescribed aspirin 75mg daily for indefinite time. Clopidogrel 75mg daily for a minimum of one month in case of BMS and for one year in case of DES. Post PCI all patients initially remained in coronary care unit and later shifted to coronary step down unit before discharge, Routine follow up was done after one week & four week of discharge.
Performa was designed to collect information including age, gender, history of diabetes (defined as a fasting glucose >126mg/dl or on treatment), hypertension BP > 140/90mm Hg or on treatment), dyslipidaemia (fasting total cholesterol >200mg/dl or on treatment), smoking, left ventricular function (visually estimated using echocardiography), presence of cardiogenic shock (defined as systolic blood pressure <90mm or requirement of inotropes to maintain a SBP > 90mm of Hg) angiographic and procedural details (culprit vessel, number of diseased vessels, use of stents, GP llb/llla inhibitors, Thrombolysis in myocardial infarction (TIMI) flow were also collected. Hospital charts were reviewed for further information including need for intubation, electrocardiogram (ECG) ST-segment analysis and laboratory data including haemoglobin, serum creatinine, cardiac enzymes etc. Timing variables were computed including time to presentation which is defined as the time from symptom onset until arrival at the hospital. Door-to-balloon time was the time from arrival at the hospital until balloon inflation in cardiac catheterization laboratory.
Coronary flow in the infarct related artery was assessed visually by the operator and classified according to the TIMI grading system on a scale of 0 to 3 both before and after the PCI.
Successful PCI was defined as visually assessed <20% residual stenosis with TIMI III distal flow. Significant groin hematoma was defined as a hematoma > 10cm in diameter or requiring blood transfusion. The primary end point was in-hospital mortality and secondary end points included 30 days out comes from discharge including mortality, reinfarction, re-current angina, congestive heart failure.
Statistical Analysis
All the variables were entered in to the statistical package for social science software, version 14(SPSS inc) for data analysis. Descriptive statistics were computed and presented as means, standard deviations were calculated for continuous variables like age, LVEF and median for onset of pain to emergency room, door to balloon time-in minutes. Categorical variables reported in percentages for the gender, hypertension, diabetes mellitus, dyslipidemia, cardiogenic shock, LVF multivessel diseases, procedural success, mortality and thirty day out come variables like myocardial infarction, recurrent angina, congestive heart failure.
Results:
A total of 73 patients were included in this study. Four patients died in hospital (5.4%). Out of four patient who died, one had cardiogenic shock during admission post discharge 30 days out comes of the studied cohort mowed no death. Major complications during one month follow up were unstable angina in 4 patient (5.7%).
Congestive cardiac failure was seen in 3 patient (4.3%).
Discussion:
Cardiologists had recognized the importance of early reperfusion in limiting ischemic damage to the myocardium. First benefit identified with the use of thrombolytic therapy to achieve reperfusion was primarily due to two land mark large trials: the Second International Study of infarct survival group (ISIS-2) 5 and an Italian group (GISSI) 6 . Both studied the effects of intravenous streptokinase given to patients with suspected acute MI. The undoubted benefits of thrombolysis are offset by its nonspecificity for the coronary circulation resulting in risk of bleeding complication and time dependent uncertainty about the efficacy of reperfusion.
In Addition there is limited evidence of the benefit of thrombolytic therapy in a number of high-risk groups including older patients and in the context of cardiogenic shock 7 . PCI has potential benefits of specific and confirmed recanalization of the culprit vessel as well as knowledge of the detailed coronary anatomy. Clinical trials comparing the efficacy of thrombolysis and primary angioplasty have concluded that superior outcomes can be obtained with an invasive approach. A meta-analysis by keeley and colleagues demonstrated that Primary PCI was better than thrombolytic therapy at reducing overall short-term death (p=0.0002), non-fatal reinfarction (p<0.0001), stroke (p=0.0004) and the combined endpoint of death, non-fatal reinfarction, and stroke (p<0.0001) 8 .
A more recent evaluation of patients recruited into the PRAGUE-2 Study found that, at 5 years after the procedure, the incidence of reinfarction, revascularization and death from all causes was considerably reduced in those patients randomized to the PCI arm compared to thrombolytic arm with p value of 0.009, <0.001 and 0.06 respectively 9 . The possible risks associated with primary PCI includes bleeding, procedure related immediate complications and radiographic contrast-related acute renal failure 10 .
As angioplasty offers reduced rates of complications, patients are discharged earlier and are less likely to be readmitted with a related cardiac event. Hospital costs are therefore considerably reduced in patients receiving PCI accounting for the reduced cost after one year 11 .
Our study shows an excellent procedural success rate (95.8%) with an excellent over all in hospital survival rate (94.5%). Out of 73 patients 71 patients presented without features of cardiogenic shock and 2 patients presented with features of cardiogenic shock. 3 patients out of 71 who presented without features of cardiogenic shock died (4.2%), which is comparable to international data which showed in hospital mortality of 5.2% in second national registry of myocardial infarction (NRM-12) 12 and 3% in ASSENT 4 trial 13 . In our study two patient had cardiogenic shock. Out of them one died (50%) which is again comparable to international data which showed higher mortality in patient with cardiogenic shock i.e 46.4% in shock registry 14 and 59.1% in American college of cardiology-National Cardio Vascular data registry (ACC-NCDR) 15 . Study from India by Reddy at al 3 and from Pakistan by Ayaz Hussain et al 16 showed an in hospital mortality of 2.2% and 1% respectively in non-cardiogenic shock group. In our country previous single study conducted by AQM Reza 4 had shown inhospital survival rate 93.8% which is also comparable to our present study where survival rate is 94.5%. In our study we used mainly bare metal stent (BMS). Drug Eluting stent (DES) was used in 9 cases. Although the use of DES and its rate on acute stent thrombosis is still debatable, majority are using BMS. Our patient treated with DES has no documented acute stent thrombosis.
Door to balloon time is an important determinant of quality of care. Recommended time as per American College of Cardiology (ACC)/ American Heart Association (AHA) guidelines is 90 minutes.However achieving this time is possible only in ideal world scenario. In developing countries like Bangladesh, financial constraints and delay in decision making due to lack of knowledge on behalf of patients and their relatives regarding importance of time in management of critical illness like myocardial infarction, turned out to be the major obstacle in following door to balloon time recommendations. In our study the median door to balloon time was 110 minutes with 40% of patients having PCI performed at or more than 90 minutes due to above mentioned reasons. However if we look at recent study by Zhang conducted in China, the median door-toballoon time reported for primary PCI was 132 min and only 22% of patients had PCI performed in <90 minutes 17 .
Our study has some limitations that deserve attention. This is our observational study performed in selected patient group. There was only three female patient in our study. So out come of primary PCI in female group could not be assessed properly. Lack of availability of IVUS was also a drawback for us to see intravascular thrombus burden and exact stent implantation.
In summary we found that primary PCI is safe and it increased the in-hospital and 30 days survival out come in patient with acute myocardial infarction. We conclude that with increasing awareness and the wider availability of primary PCI, this procedure will be performed more frequently and thrombolytic therapy will no more be the first choice therapy for treatment of STEMI in our set up.
